Martin Edelman, MD, Talks About Improving Outcomes in the Management of NSCLC
Martin Edelman, MD, Greenbaum Cancer Center, Baltimore, MD, says that organizations like NCCN and ASCO have guidelines for the management of non-small cell lung cancer (NSCLC). "I think that by utilizing these various clinical as well as biological markers, we can develop therapies that are tailored to the individual patient and have substantial evidence to support their use," said Dr Edelman.
This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.
Converting to for-profit status has a positive influence on a hospital’s finances, but no effect on quality or mortality rates, found researchers from the Harvard School of Public Health and Brigham and Women’s Hospital.
The study, published in Cell Stem Cell, identified a microRNA-mediated inhibitory pathway that repressed expression of the speech and language gene FOXP2, promoting metastases of breast cancer cells to distant sites.
More than 53,000 managed care clients in 6 western New York counties will not have to find a new insurer, thanks to an emerging partnership that caused the area’s BlueCross BlueShield carrier to reverse its decision to exit the health plans.